ELVN - Enliven Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ELVN is currently covered by 2 analysts with an average price target of $32.57. This is a potential upside of $11 (51%) from yesterday's end of day stock price of $21.57.

Enliven Therapeutics's activity chart (see below) currently has 0 price targets and 4 ratings on display. The stock rating distribution of ELVN is 100% BUY.

Stock Analyst Price Targets - Review

Highest price target for ELVN is $37, Lowest price target is $37, average price target is $37.

Most recent stock forecast was given by ROBERT BURNS from HC WAINWRIGHT on 01-Oct-2024. First documented stock forecast 09-Sep-2024.

Best performing analysts who are covering ELVN - Enliven Therapeutics:

Robert Burns

Currently out of the existing stock ratings of ELVN, 4 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Robert Burns (HC WAINWRIGHT)

Buy

$37

$15.09 (68.87%)

$37

8 months 17 days ago
(01-Oct-2024)

0/2 (0%)

$11 (42.31%)

Please subscribe to see the analyst performance score

Show more analysts

Load Price Targets and Ratings Chart

To gain access for the analyst/ stock price target chart please use a computer

What is ELVN (Enliven Therapeutics) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on ELVN (Enliven Therapeutics) with a proven track record?

ROBERT BURNS

Which analyst has the most public recommendations on ELVN (Enliven Therapeutics)?

Robert Burns has 23 price targets and 19 ratings on ELVN

Which analyst is the currently most bullish on ELVN (Enliven Therapeutics)?

Robert Burns with highest potential upside - $15.09